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According to the literature, intense pulsed light (IPL) represents a versatile tool in the treatment of some dermatological conditions
(i.e., pigmentation disorders, hair removal, and acne), due to its wide range of wavelengths. The authors herein report on 58
unconventional but effective uses of IPL in several cutaneous diseases, such as rosacea (10 cases), port-wine stain (PWS) (10 cases),
disseminated porokeratosis (10 cases), pilonidal cyst (3 cases), seborrheic keratosis (10 cases), hypertrophic scar (5 cases) and keloid
scar (5 cases), Becker’s nevus (2 cases), hidradenitis suppurativa (2 cases), and sarcoidosis (1 case). Our results should suggest that
IPL could represent a valid therapeutic support and option by providing excellent outcomes and low side effects, even though
it should be underlined that the use and the effectiveness of IPL are strongly related to the operator’s experience (acquired by
attempting at least one specific course on the use of IPL and one-year experience in a specialized centre). Moreover, the daily use of
these devices will surely increase clinical experience and provide new information, thus enhancing long-term results and improving
IPL effectiveness.
1. Introduction
First introduced in 1990s, intense pulsed light (IPL) was
obtained by U.S. Food and Drug Administration (FDA)
authorization in 1995 for the treatment of lower-limb telang-
iectasias.
This polychromatic, noncoherent, and broad-spectrum
pulsed light source (xenon lamp) is able to emit light of
a wavelength between 390 nm and 1200 nm [1]. Its basic
principle consists in the absorption of photons by exoge-
nous or endogenous chromophores within the skin; this
transfer of energy to the target structures generates heat
and subsequent destruction of the target through a process
called selective photothermolysis. The wavelength should be
selected in dependence of the absorption peak of the target
chromophore and the pulse duration should last less than the
thermal relaxation time. This limits the diffusion of heat and
damage to surrounding structures.
The main chromophores of the skin, such as haemo-
globin, melanin, and water, have a broad absorption spec-
trum. Through the use of a filter, available from 500 nm to
755 nm, it is possible to select the wavelengths suitable for
the established treatment.The IPL’s pulse durationmay be set
within a relatively wide range between 1 and 100milliseconds,
depending on the selected device. In addition, a wide range
of treatment parameters, including pulse sequence and pulse
delay time, can be customized, thus giving users greater
versatility and accuracy [1].
Versatility represents a significant advantage for expe-
rienced dermatologists, but it could be a serious limit for
nonexperienced physicians and for nonmedical staff since
an erroneous selection of the setting can cause serious side
effects.
In daily practice, the application of a gel is necessary, as
well as direct contact between the handpiece and the skin,
although this hinders the local immediate response.
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Table 1: Clinical data.
Number of patients Gender Mean age (range)
Rosacea 10 5 M, 5 F 51.6 (38–62)
Port wine stain 10 7 M, 3 F 52.1 (8–52)
Disseminated Porokeratosis 10 2 M, 8 F 58.3 (41–70)
Pilonidal cyst 3 3 M 24.6 (18–34)
Seborrheic keratosis 10 6 M, 4 F 61.7 (35–83)
Hypertrophic scar/keloids 5/5 3 M, 2 F/2 M, 3 F 30.2 (21–37)/34.8 (27–43)
Becker’s nevus 2 2 M 29 (26–32)
Hidradenitis suppurativa 2 1 M, 1 F 32 (26–38)
Sarcoidosis 1 1 F 26
Total 58 32M, 26F 42.7 (8–83)
The combination of wavelength, pulse duration, delay,
and fluence allows the use of IPL devices in the treatment
of several dermatological conditions, such as acne vulgaris,
pigmentation disorders, vascular lesions, hirsutism, photo-
damaged skin, scars and birthmarks, and melasma [2–4].
The authors herein suggest many unconventional uses of
IPL in the treatment of different dermatological conditions,
such as rosacea (10 cases), port-wine stain (PWS) (10 cases),
disseminated porokeratosis (10 cases), pilonidal cyst (3 cases),
seborrheic keratosis (10 cases), hypertrophic scar (5 cases)
and keloid scar (5 cases), Becker’s nevus (2 cases), hidradeni-
tis suppurativa (2 cases), and sarcoidosis (1 case).
Acne rosacea or rosacea is a chronic dermatitis of
unknown aetiology, characterized by erythema, telangiec-
tasias, papules and pustules [5, 6].
Port-wine stain is a common congenital vascular malfor-
mation occurring in up to 25% of infants [7–10].
Disseminated porokeratosis is a localized alteration of ker-
atinization. Clinically, one or more atrophic mainly asymp-
tomatic and sometimesmildly itching plaques surrounded by
an hyperkeratotic border (histologically defined as a cornoid
lamella) are observed due to a rapid proliferation of atypical
keratinocytes [11–14].
Pilonidal cyst, also known as pilonidal sinus or sacrococ-
cygeal cyst (due to its frequent onset in this area), is a cyst
containing hair and skin debris [15–19].
Seborrheic keratosis is a benign skin lesion of the epider-
mis, mainly localized on seborrheic areas, in particular, the
face and trunk. The most common clinical presentation is
a lesion with warty or squamous crusted surface of variable
size, coloured yellow-brown or dark-brown with blackish
specks, with soft consistency [20, 21].
Hypertrophic scars and keloids are a serious physical and
psychological dermatological condition for patients. Despite
the several studies performed on metabolisms and treatment
of wounds and scars, the exact pathogenesis of keloids
and hypertrophic scars remains unknown and this makes
therapies even more complicated [22].
Becker’s nevus is a mostly male-predominant birthmark
hyperpigmentation, presenting with a unilateral (rarely bilat-
eral), benign hypermelanotic patch usually sited on the shoul-
der, chest, or lower back. Grouped brown spots with a bizarre
border are the common presentation, with hypertrichosis in
half of the cases [23, 24].
Hidradenitis suppurativa is a common disease, also
known as acne inversa, which leads to a chronic relapsing
suppurative inflammation of regions where apocrine glands
occur, that is, axilla, inguinal folds, perineum, genitalia,
and periareolar region. Several predisposing, triggering, and
etiologic factors have been encountered (androgenic dys-
function, obesity, etc.); thus, authors agree that aetiology is
still unclear. Commonly, the follicles into which the apocrine
glands open are plugged by keratin and infections, mainly
caused by anaerobic organisms which develop the following
stasis and cause cysts that are extremely painful to palpation
[25–27].
Sarcoidosis is both a systemic and a dermatologic syn-
drome of unknown etiology which can affect the skin as well
the lymph nodes and viscera. The lesions can be single or
multiple and can range from macules to large plaques and
nodules. Cutaneous involvement is referred to in up to 25%
of patients with systemic sarcoidosis. Plaques,maculopapular
eruptions, subcutaneous nodules, and lupus pernio can be
observed as well as cutaneous manifestations [28–33].
2. Material and Methods
58 consecutive patients (32 males and 26 females, mean age
42.7—range 8–83) presenting with nine different dermato-
logical disorders were treated with IPL as an unconventional
approach (Table 1). The aim of the study was to verify the
efficacy of IPL by comparing the obtained results with results
achieved through conventional treatment options (according
to the literature) using either clinical or dermoscopic pictures
before and after each session. Notably, dermoscopy con-
ducted before treatment confirmed its usefulness in confirm-
ing diagnosis and in highlighting specific characteristics of
each condition, such as number and calibre of blood vessels,
distribution of pigment, and presence of crusts or hairs; thus,
it also represents a valid method for outcome assessments
[34]. An IPL device (DekaM.E.L.A. Srl, Calenzano, Florence,
Italy) with two different handpieces for 500 nm and 550 nm
filters was used and set according to the skin type and clinical
characteristics of each patient. Dermoscopic images were
made in all cases before, immediately after and at distance
from each treatment using a special lens for dermoscopy
(DermLite Foto, 3GEN LLC, San Juan Capistrano, CA, USA)
connected to a digital camera (Canon PowerShot A360).
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Table 2: IPL setting for each off-label dermatological disease treated.
Filters Number of pulses Pulse duration Delay Fluence Number of sessions
Rosacea erythematotelangiectatic
component 500 2 5–10msec 10msec 12–16 J/cm
2 Up to 4
Rosacea papulopustular component 550 2 5–10msec 10msec 10–12 J/cm2 Up to 5
Port wine stain 500 2 5–10msec 10msec 13–16 J/cm2 Up to 5
Disseminated porokeratosis 550 2 5–10msec 10msec 10–12 J/cm2 Up to 4
Pilonidal cyst 550 3 5msec 20msec 7–9 J/cm2 Up to 3
Seborrheic keratosis 550 2 5–10msec 10msec 10–12 J/cm2 2
Hypertrophic scar and keloid
pigmented component 550 2 5–10msec 10msec 10–12 J/cm
2 Up to 5
Hypertrophic scar and keloid
vascular component 500 2 5–10msec 10msec 14–17 J/cm
2 Up to 6
Becker’s nevus
hair removal 550 2-3 5msec 10–20msec 7–9 J/cm
2 Up to 4
Becker’s nevus
pigmented component 550 2 5–10msec 10msec 9–12 J/cm
2 Up to 5
Hidradenitis suppurativa hair
removal 550 2-3 5msec 10–20msec 7–9 J/cm
2 Up to 4
Hidradenitis suppurativa
inflammatory component 550 2 5–10msec 10msec 8–10 J/cm
2 Up to 5
Sarcoidosis 500 2 5–10msec 10msec 12–16 J/cm2 Up to 4
A soothing cream, a gentle cleansing, and a photoprotec-
tion (SPF50) solution were prescribed to each patient after
each session.
In the following, the authors describe the IPL scheme
treatments and the results obtained for each dermatological
condition. Each patient has been informed that at least two
sessions up to six sessions, with intervals of approximately
20–30 days, are needed to gain significant results.
Rosacea. Ten patients (5 females and 5 males) aged between
38 and 62 years (average age 51.6 years) with Fitzpatrick
phototype II-III presented with rosacea, 6 with an erythema-
totelangiectatic form, 3 with papules and pustules, and only
one with rhinophyma.
The telangiectatic component was treated with the
500 nm handpiece, while the papulopustular component was
subsequently treated with the 550 nm handpiece (Table 2).
Port-Wine Stain. Ten patients (7 males and 3 females) aged
between 8 and 52 years (average age 22.1 years) with Fitz-
patrick phototype II-III were treated for the presence of a
PWS. Lesions were sited on the malar part of the face (3
cases), on the nose (2 cases), on the glabella (1 case), on the
upper lip (1 case), on the forehead (1 case), on the posterior
part of the neck (1 case), and on the posterior upper-right
limb (1 case), respectively. Table 2 shows the IPL setting used
in these cases.
Disseminated Porokeratosis. Ten patients (8 females and 2
males) aged between 41 and 70 years (average age 58.3
years) with Fitzpatrick phototypes II–IV were treated for
the presence of multiple disseminated, atrophic, and slightly
itchy plaques with a hyperkeratotic border. The lesions were
mainly located on the lower extremities (50%), on the upper
extremities (40%), and on the back (10%). Protocol shown on
Table 2 has been successfully applied to these patients.
Pilonidal Cyst.Three patients (3males) 18, 22, and 34 years old
(average age 24.6 years) presented with a recurrent, inflamed,
sore, and swollen cyst localized in the sacrococcygeal region.
The lesion of the oldest patient had already been surgically
treated. IPL action on hair follicles is well known and
we thus suggested the use of this device with the aim of
destroying hairs encapsulated within the cyst and hairs in the
surrounding area. The anti-inflammatory properties of IPL
proved to be effective in reducing the risk of recurrence. We
decided to treat the lesion according to the protocol shown
on Table 2.
Seborrheic Keratosis. Ten patients (6 males and 4 females)
aged between 35 and 83 years (average age 61.7 years) with
Fitzpatrick phototypes I–III were treated for the presence
of multiple disseminated small seborrheic keratoses sited
on the face (30%), on the chest (25%), and on the back
(45%).
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Figure 1: Rosacea: significant results with a significant reduction in vessel number and size and a complete disappearance of papules have
been achieved after 4 IPL sessions.
All lesions were treated at intervals of 15–20 days for a
total of 4 sessions per case according to the protocol shown
in Table 2.
Dermoscopic images were obtained for each case before
(also for diagnostic purpose), immediately after, and at a
distance from each treatment using the same equipment
described above.
Hypertrophic Scars and Keloids. Ten patients, 5 presenting
with hypertrophic scars (3 males and 2 females aged between
21 and 37 years, average age 30.2 years) and 5 presenting
with keloids (3 females and 2 males aged between 27 and 43
years, average age 34.8 years), were treated with both 500 nm
(vascular component) and 550 nm (pigmented component)
wavelength handpieces. The first sessions with the 550 nm
handpiece were carried out for the pigmented component
where present. Whereupon, successive treatments with the
500 nm handpiece have been made for treating the vascular
component (Table 2).
At least 30 days of rest are required before the subsequent
session and a few months are needed to obtain very positive
results.
Becker’s Nevus. A 32-year-old man presented with Becker’s
nevus sited on his left shoulder blade. Clinically, a hypertri-
chotic brown patch with irregular edges of 12 cm × 9 cm in
size was observed. Successively, a 26-year-old man presented
with Becker’s nevus without hypertrichosis of 8,5 cm × 8 cm
in size and sited on his upper-right chest. In the first case, we
decided to first use a 550nm wavelength handpiece with the
aim of removing the hair components (Table 2).
After four sessions of IPL at intervals of 40 days, we
performed two additional sessions with the aim of treating
the hyperpigmented component (Table 2). Only the protocol
shown in Table 2 was applied to the second patient since the
hypertrichotic component was not present.
Hidradenitis Suppurativa. One 38-year-old man, previously
treated in a surgical way (clinical stage II (Hurley’s stag-
ing system) and sartorius score of 36), and one 26-year-
old woman presented with hidradenitis suppurativa of the
axillary region, bilateral (clinical stage I (Hurley’s staging
system) and sartorius score of 24).
After four sessions of IPL at intervals of 15–20 days,
we performed two additional sessions with 2 pulses of 5ms
and 10ms separated by a delay of 10ms and a fluence of
9 J/cm2 with the aim of treating the inflammatory component
(Table 2).
Sarcoidosis. A 26-year-old female presented with three
painful, firm, and vascularized nodules sited on the anterior
and posterior parts of the pinna and on the helix. Through
histopathological examination, a diagnosis of sarcoidosis was
posed. The patient had already undergone intralesional cor-
ticosteroid therapy without results. Thus, we suggested using
the IPL device with the aim of hitting the very prominent
(especially on dermoscopic evaluation) vascular component
within the lesions.
3. Results
In this study, we obtained good outcomes for all the treated
patients, who were affected by different dermatological con-
ditions. Our results are summarized as follows.
Rosacea. Patients required from 2 to 5 sessions, at intervals
of approximately 20–30 days, to gain significant results, even
though amoderate reduction in vessel number and size and a
partial disappearance of papules were observed subsequent to
the second session (Figure 1). A 12-month follow-up revealed
the complete absence of recurrences and the persistence of
the achieved outcomes in 7 of 10 patients (70%) whereas the
other 3 patients required a new treatment within the year for
the slight relapse of the papulopustular component.
Port-Wine Stain. The results were already visible after the end
of the first session. Dermoscopy performed before treatment
highlighted the number, calibre, and depth of the target
vessels. Superficial vessels were hit with greater accuracy
by IPL and dermoscopic examinations revealed a change in
vessel colour from red to blue immediately after treatment.
In cases of high numbers of vessels, erosions and crusts can
follow treatment sessions for several days. The number of the
treatments required to gain significant results depended on
the depth and site of the PWS.
Three out of 10 patients (30%) obtained excellent results
(disappearance of PWS), 6 of 10 (60%) obtained good results
(disappearance of almost 70% of treated vessels), and only
one (10%) obtained amoderate result (disappearance of about
30% of the lesion) (Figure 2).The obtained results, confirmed
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Figure 2: Port-wine stain: after 4 IPL sessions, the patient gained excellent results.
Figure 3: Disseminated porokeratosis: after 4 treatments, an important reduction of the hyperkeratotic edge and a reduction in the intensity
of melanin have been observed.
by dermoscopy, were stable after a follow-up period ranging
from 1 to 3 years.
Disseminated Porokeratosis. All treated patients showed inter-
esting results, despite the fact that the histology confirmed the
persistence of cornoid lamella. In fact, one patient who had
shown significant improvements after four sessions presented
at the follow-up visit with an important reduction of the
hyperkeratotic edge and a reduction in the intensity of
melanin (Figure 3); a punch biopsy was performed and the
histopathologic examination revealed the persistence of a
cornoid lamella.
Pilonidal Cyst. A complete resolution was achieved by the
third session (80 days after the first visit) in 3 patients treated.
(Figure 4) After a follow-up period of 5 years, for the first
patient treated, and one year, for the other two, no recurrence
has been observed.
Seborrheic Keratosis. Superficial and small seborrheic ker-
atoses responded well to IPL, whereas larger and/or deeper
lesions may require a CO
2
laser or other treatment. Der-
moscopy is useful either to confirm diagnosis or to demon-
strate a change in lesion colour from brown to grey immedi-
ately after treatment, thus predicting a good response to the
treatment. Seborrheic keratosis was usually resolved with a
mild inflammation and a complete recovery within 30 days
after an average of two treatments (Figure 5).
Hypertrophic Scars and Keloids. Dermoscopic images reve-
aled a significant reduction of vascular component in the
thicker areas. Scars flattened and became smaller after three
sessions. (Figures 6 and 7) All in all, good results were
achieved, even though lengthy treatment (several months) is
needed. The obtained results were stable during the follow-
up. In one out of 5 cases of keloids, the lesion has resumed its
growth phase.
Becker’s Nevus. A progressive hair removal and a reduction
of the hyperpigmented area were achieved to the good
satisfaction of both patients (Figure 8).
Hidradenitis Suppurativa. At the end of the suggested scheme
protocol, hidradenitis suppurativa was completely removed
in both its inflammatory and painful components; hair
removal was also achieved (Figure 9).
Sarcoidosis. A significant reduction of the vascular compo-
nent and in the consistency of the lesions was achieved, thus
leading to pain disappearance (Figure 10).
4. Discussion
In this study, we report on our good results achieved with
almost all 58 patients affected by different dermatological
conditions. With the aim of providing more exhaustive
details, we will briefly discuss each condition separately.
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Figure 4: Pilonidal cyst: a complete resolution was achieved by the third session.
Figure 5: Hidradenitis suppurativa: complete resolution of pustular-papules progressive hair removal after 3 IPL treatments, bilaterally.
Clinical stage I (Hurley’s staging) and sartorius score of 24.
(a)
(b)
Figure 6: Seborrheic keratosis: (a) significant reduction of multiple seborrheic keratoses of the face after 2 IPL sessions, (b) seborrheic
keratoses of the back disappeared after 2 IPL sessions.
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Figure 7: Hypertrophic scar: significant reduction of vascular component in the thicker areas before and after 3 IPL treatments.
Figure 8: Keloid: scar after three sessions of IPL. Dermoscopy performed immediately after the first treatment showed a variation of the color
from red-blue to red.
Rosacea. Treatment of clinical manifestation of rosacea usu-
ally involves lasers such as argon, pulsed dye, Nd:YAG, CO
2
,
and KTP, frequently causing burns, pain, and outcomes such
as scars and significant hyperpigmentation due to incautious
assessment of the lasers’ photophysical parameters.
The ability to choose the duration of pulses makes IPL
a versatile tool in the treatment of rosacea. The possibility
of different filter settings (515, 550, 560, 570, and 590 nm)
allows a wider selection of the range colour of the vascular
system. A surface of 2.8 cm2 can be treated with a single shot,
in contrast to the pulse dye laser (1.96 cm2 or 0.78 cm2) and
argon (3mm2). The larger surface offers greater efficiency, in
terms of reducing treatment sessions, and less discomfort for
the patient. Because it is able to divide the energy into two
or three pulses with different delays between one pulse and
the next, IPL allows the skin to cool down with minimal side
effects [5].
Since the treatment is relatively unpainful, it can be
carried out in the absence of anaesthesia. Immediate response
usually presents as a slight erythema and a purple colouring
which spontaneously resolves within 24–96 hours [5].
In a pilot study conducted byMark et al., a 30% reduction
of blood flow, a 29% reduction of telangiectasias, and a
21% reduction of erythema have been observed after five
sessions of IPL. Taub et al. noticed a reduction of 83% of
erythema, a reduction of 75% of flushing, and an improved
skin texture [5, 6]. A 2008 study performed by Papageorgiou
et al. noted the effectiveness of IPL in the treatment of rosacea
disease of phase I. It showed a significant improvement of
erythema, telangiectasias, and flushing. Severity was reduced
and persistent results at 6 months with minimal side effects
were obtained [2]. Reduction in the mechanical integrity
of connective tissue of the dermis surface, responsible for
passive dilatation of the blood vessels and thus resulting in
erythema, telangiectasia, release of inflammatory mediators,
and the formation of inflammatory papules and pustules,
seems to play a key role in the treatment of rosacea.Moreover,
IPL can improve rosacea through the ablation of its abnormal
vessels and through the collagen remodelling of the dermis.
Furthermore, IPL determines a significant reduction of
inflammation and in the number of active sebaceous glands,
thus blocking, with great effectiveness, the altered process of
keratinization [6].
In our study, all patients achieved significant results with
2 to 5 sessions of treatment.
Port-Wine Stain. Lasers such as the pulse dye laser, Nd:YAG,
alexandrite, and the diode laser are the most used ones in the
treatment of PWS [7, 8].
Currently, the first-choice treatment for PWS is rep-
resented by the pulsed dye laser; unfortunately, it cannot
completely remove PWS. The energy emitted reaches only
superficial vessels, thus resulting in a decreased amount of
available light to hit the deeper ones (shadow effect). Because
of this effect, hyper- and hypopigmentation and atrophic and
hypertrophic scars may result after treatment [10]. When a
PWS, especially with nodular component, is treated with an
external light source, the main goal is to reach the vessels
localized at the lower surface. IPL, thanks to its variability of
pulse and fluence and to its possibility to divide the energy
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Figure 9: Becker’s nevus: a progressive hair removal and a reduction of the hyperpigmented area were achieved to the good satisfaction of
the patient.
Figure 10: Sarcoidosis: significant reduction of the nodules with diminution of the painful sensation after 3 IPL treatments.
into different pulses, allows an additional heating which
leads to coagulation of blood vessels of different diameter
and different depth [1, 8]. Raulin et al. reported a 70–99%
resolution of pink-coloured PWS after 2.9 treatments, of red
PWS after about 1.4 treatments, and of purple PWS after
an average of 2.4 sessions. In a study by Ozdemir et al.,
37 patients with PWS were evaluated with results of up to
100% in 7 patients and 70–99% in 14 patients. In fact, IPL
can be considered an effective treatment option. However,
IPL systems require considerable experience and should be
conducted with the aid of a good dermoscopy in order to
determine the type of vessels to treat [34].
Disseminated Porokeratosis. Potential therapies include topi-
cal 5-fluorouracil, oral retinoids, CO
2
laser, pulse dye laser,
Nd:YAG, cryotherapy, dermabrasion, surgical excision, and
imiquimod, or a combination of several therapies simultane-
ously [11–14].
In cases of superficial actinic porokeratosis, IPL proves to
be a valid therapeutic option by determining a destruction
of the pigment without risk of scarring or other side
effects.
Pilonidal Cysts and Hidradenitis Suppurativa. According to
the literature, laser technology applied in such cases includes
CO
2
laser and Nd:YAG. For its photocoagulative action,
CO
2
laser treatment produces a precise wound with minimal
blood loss, leaving a surgical field clean and dry, but it is able
to coagulate large vessels and requires a long recovery period
[16–19].
IPL may represent a valid option for such lesions. The
broad light spectrum is absorbed by the hair shaft, generates
heat, and destroys the hair follicle. IPL acts on the melanin
of the hair follicle causing necrosis of the follicle within the
cyst. Similarly, it acts on the hairs of the surrounding area in
order to reduce recurrence. Moreover, IPL has proven to be
a powerful anti-inflammatory treatment able to eliminate the
chronic inflammationwithin the cyst [19]. In 2011, Highton et
al. selected 18 patients affected by HS and treated one axilla,
groin, or inframammary area with intense pulsed light two
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times per week for 4 weeks using a harmony laser, whereas
the contralateral side received no treatment and was used as a
control. A significant improvement in the mean examination
and its persistence at 12 months led patients to report high
levels of satisfaction. No concurrent improvement on the
untreated control side has been observed. This small study
suggests that intense pulsed light may be an effective treat-
ment for HS. Although only a few data have been reported so
far, results suggest efficacy and safety and the absence of side
effects [26].
Seborrheic Keratosis. In previous studies, lasers have been
demonstrated to be effective in the treatment of seborrheic
keratosis, such as alexandrite (755 nm) and diode laser [21].
No studies on the use of pulsed light for the treatment
of seborrheic keratosis have been published so far. Thanks
to its broad spectrum of action, it is possible to select the
specific wavelength to act selectively on the melanin pigment
of seborrheic keratosis. Immediately after the treatment,
a change in colour from brown to grey is observed at
dermoscopic evaluation and this represents a sign of success
of the performed procedure [34]. Subsequently, keratosis
tends to disappear completely without residual erythema.
The treatment is, however, limited to superficial and small
seborrheic keratoses.
Hypertrophic Scars and Keloids. The pulse dye laser has
been reported to produce long-term improvements in the
appearance of hypertrophic scars. A very recent pilot study
has demonstrated the effectiveness of IPL in wound heal-
ing after suture removal. The basic mechanism is not yet
fully understood but most probably an action on vascular
proliferation, essential for the growth of collagen, and on
pigmentation resulting from scar formation is involved [22].
Despite thewide use of IPL in various skin diseases, only a few
studies demonstrating its effectiveness on hypertrophic scars
have been published to date. Wavelengths around 1200 nm
are absorbed by the water within the dermis thus triggering
a reaction that leads to cytokine stimulation of collagen
fibres of types I and III and elastin. The absorption peak of
the collagen fibres is found to be from 400 nm to 600 nm.
The heating of the collagen fibres by the IPL leads to their
contraction, with a clinically detectable improvement in the
texture. The IPL, in contrast to other treatments, is not
invasive and has very few side effects. Bellew et al. have
shown that the IPL is as effective as the long pulse dye laser
(595 nm), resulting in a greater softness of the scar. Kontoe
et al. reported an improvement of more than 75% in the
pigmentation of hypertrophic scars, 50% higher than that in
the scars from asphalt, and 50% reduction in the size and
thickness of hypertrophic scars. This is probably due to the
inhibition of the action of the vessel caused by IPL on scar
tissue and on the subsequent proliferation of collagen [22].
Becker’s Nevus. Trelles et al. compared the effectiveness of the
Erbium:YAG laser with theNd:YAG laser in 22 Becker’s nevus
patients, 11 for each group. Up to now, there have been no
studies on the treatment of Becker’s nevus with IPL. Such
treatment is able to produce synchronized single or multiple
pulses with the possibility of varying the pulse duration.
We can then select the appropriate wavelength, taking into
account the main absorption spectrum of the pigmented
structures (between 400 nm and 600 nm) and the right pulse
duration to act efficiently on the hair follicle. We can operate
on both components with excellent results. [23, 24].
Sarcoidosis. In his systematic review on the use of pulsed
dye laser in the treatment of inflammatory skin diseases
published in 2013, Erceg A reported on five case reports of
PDL treatment for cutaneous sarcoidosis/lupus pernio [28–
33]. In our experience, IPL has been proven to have a signif-
icant effect on the vascular component of granulomata. Even
though IPL could not definitely treat cutaneous sarcoidosis, a
great improvement of patients’ pain and symptoms could be
achieved.
5. Conclusions
According to the literature, the effectiveness of IPL has now
been well demonstrated. Its versatility, in contrast with many
single-laser spectrums, has led to its rapid spread in different
clinical scenarios, while the wide range of wavelengths allows
us to use these devices for a broader range of clinical condi-
tions. However, we would like to underline how the use and
effectiveness of the IPL are strongly related to the operator’s
experience. Apart from facilitating excellent outcome, the
broad spectrum of wavelengths used and the high number
of parameters can affect the final result and increase the
risk of side effects. The daily use of these devices will surely
increase clinical experience and provide new information,
thus enhancing long-term results and improving IPL effec-
tiveness.
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